Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,483.00
+4.30 (0.29%)
Apr 24, 2025, 12:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 243.63 billion as of April 23, 2025. Its market cap has decreased by -18.45% in one year.
Market Cap
243.63B
Enterprise Value
218.69B
Revenue
57.29B
Ranking
n/a
PE Ratio
34.58
Stock Price
1,483.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 243.63B, a decrease of -18.00%. That is a compound annual growth rate of -4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 239.05B | -18.46% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,202.44B |
| Divi's Laboratories | 1,564.01B |
| Cipla | 1,223.70B |
| Mankind Pharma | 1,065.11B |
| Apollo Hospitals Enterprise | 1,017.06B |
| Zydus Lifesciences | 836.73B |
| Aurobindo Pharma | 680.47B |
| Alkem Laboratories | 592.24B |